Clinical Trial

Radiation-induced Toxicity of the Heart

Study acronym: CorTox
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
Late side effects in radio(chemo)therapy \[R(CH)T\] pose a critical limitation to patients' overall survival and quality of life. Even though toxicities of the heart are highly relevant for patients with cancer in the thoracic region, risk stratification models for these toxicities are lacking. In this study, liquid, functional and imaging biomarkers are being investigated for their use in prediction of cardiac toxicity following R(CH)T for patients with thoracic malignancies.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-05-15.
Trial Details
NCT Number NCT06986291
Lead Sponsor Technische Universität Dresden
Conditions Non-small Cell Lung Cancer, Esophageal Cancer, Breast Cancer Female
Enrollment 325 participants
Start Date 2025-08
Primary Completion 2034-12 (estimated)
Study Completion 2039-12 (estimated)
Updated on ClinicalTrials.gov 2025-05-29